Clinical Trials on Yellow Fever Vaccine

Total 2722 results

Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation

Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination

Yellow Fever Vaccine

United States
The Immunobiological Technology Institute (Bio-Manguinhos)...
Wellcome Trust

Unknown

Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study

Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military

Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Ministry of Health, Brazil

Active, not recruiting

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

Immunity | Yellow Fever Vaccine

Brazil
Centre Hospitalier Universitaire Saint Pierre

Active, not recruiting

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

HIV Infections | Yellow Fever Vaccine

Belgium
Singapore General Hospital

Completed

Yellow Fever Vaccine on Statin/ Non Statin Subjects

Yellow Fever | Yellow Fever Vaccine

Singapore
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (VYF02)

Yellow Fever (Healthy Volunteers)

United States
US Army Medical Research Institute of Infectious...

Completed

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Yellow Fever Vaccination Reaction

United States
Sanofi Pasteur, a Sanofi Company

Completed

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults (VYF01)

Yellow Fever (Healthy Volunteers)

United States
Tysana Pte Ltd

Completed

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Treatment of Acute Yellow Fever Virus Infection

Singapore
University of Aarhus
Martin Tolstrup

Enrolling by invitation

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination (CYF-8)

Healthy | Cytotoxicity | Yellow Fever Vaccination Reaction

Denmark
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

Yellow Fever | Yellow Fever Immunisation

United States
Alba Maria Ropero
Centers for Disease Control and Prevention; Ministry of Public Health, Argentina

Completed

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Vaccine Response Impaired

Argentina
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Malaria | Malaria Vaccines

Ghana
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children

Vaccines, Pneumococcal | Vaccines, Pneumococcal Conjugate Vaccine
Serum Institute of India Pvt. Ltd.

Recruiting

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants

Yellow Fever

Gambia, Mali
Serum Institute of India Pvt. Ltd.

Not yet recruiting

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Yellow Fever

Kenya
London School of Hygiene and Tropical Medicine

Not yet recruiting

Booster Vaccine for Yellow Fever (BoVY)

Yellow Fever
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Sanofi Pasteur, a Sanofi Company

Completed

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

Yellow Fever

Korea, Republic of
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Immunity After Two Doses of Yellow Fever Vaccine (IATDYFV)

Yellow Fever

Brazil
Pfizer

Completed

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Vaccines, Pneumococcal Conjugate Vaccine

United States, Spain, France, Canada, Germany, Czechia, Sweden, Belgium, Poland, Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine

South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Prevenar Immunogenicity in High Risk Children

Vaccines, Pneumococcal Conjugate Vaccine
Leiden University Medical Center
The International Society of Travel Medicine

Recruiting

Yellow Fever Human Infection Model With YF-17D (YF-INFECT)

Yellow Fever

Netherlands
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
Centers for Disease Control and Prevention
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Infectious...

Unknown

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Yellow Fever
Oswaldo Cruz Foundation

Unknown

Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children

Yellow Fever

Brazil
GE Healthcare

Completed

Trial of Yellow Fever Inactivated Vaccine

Yellow Fever

United States
Rockefeller University
Emory University

Completed

Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults

Yellow Fever

United States
Najit Technologies, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Trial of an Inactivated Yellow Fever Virus Vaccine

Yellow Fever

United States
Epicentre
Kenya Medical Research Institute

Completed

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) (YEFE)

Yellow Fever

Uganda, Kenya
Sanofi Pasteur, a Sanofi Company

Completed

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Yellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic Fever

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Vaccines, Combined | Hexavalent Vaccine

Germany, Italy, Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil

Vaccines, Pneumococcal Conjugate Vaccine

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants

Vaccines, Pneumococcal Conjugate Vaccine

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Vaccines, Pneumococcal Conjugate Vaccine

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)

Vaccines, Pneumococcal Conjugate Vaccine

Philippines
Oregon Health and Science University

Recruiting

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

Yellow Fever | Immunization; Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Yellow Fever | Dengue | Dengue Hemorrhagic Fever

Peru, Colombia
Pfizer

Completed

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Pneumococcal Vaccines | Pneumococcal Conjugate Vaccine

Japan
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

Yellow Fever

United States, Uganda
French National Agency for Research on AIDS and...

Completed

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (EP46 NOVAA)

HIV Infection | Yellow Fever

France
Sri Edupuganti
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Recruiting

Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine

Yellow Fever

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Vaccines | Pneumococcal Conjugate Vaccine

Taiwan
University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program; Institut Pasteur; MRC/UVRI... and other collaborators

Completed

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine (NIFTY)

Yellow Fever

Kenya, Uganda
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Dengue

United States
University of Surrey
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Innovative Medicines Initiative

Completed

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Healthy

United Kingdom
University of Auckland, New Zealand

Completed

The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination

Vaccination

New Zealand

Clinical Trials on Yellow Fever Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations